Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'Responses Against Paramyxoviruses in T cells with crOss Reactivity'. The following are the other r... Read More
U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07780695) titled 'Effect of Adapted Physical Activity on Emotion Regulation in People With Depressive Disorde... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'Effect of innate immune reprogramming by primary dengue on host response to secondary dengue'. The... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'Validation of Gore Test in patients with Sphincteric Dyssynergia presenting with Dysfunctional Voi... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'An open-label, randomized, controlled phase 3 study of enfortumab vedotin in combination with pemb... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A double-blind, randomised, placebo-controlled trial evaluating the efficacy and safety of oral ne... Read More
U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07778277) titled 'Personalized Sensory Stimulation: Urban and Rural Dementia Care' on Aug. 18. Brief Summary... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending ... Read More